{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T05:20:07Z","timestamp":1784092807127,"version":"3.55.0"},"reference-count":86,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,5,12]],"date-time":"2019-05-12T00:00:00Z","timestamp":1557619200000},"content-version":"am","delay-in-days":406,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA033572"],"award-info":[{"award-number":["P30CA033572"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.bbcan.2018.01.003","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T10:31:25Z","timestamp":1517394685000},"page":"128-137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["EphB4: A promising target for upper aerodigestive malignancies"],"prefix":"10.1016","volume":"1869","author":[{"given":"Ravi","family":"Salgia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash S.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2018.01.003_bb0005","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cell.2008.03.011","article-title":"Eph-ephrin bidirectional signaling in physiology and disease","volume":"133","author":"Pasquale","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2018.01.003_bb0010","doi-asserted-by":"crossref","first-page":"G908","DOI":"10.1152\/ajpgi.00510.2009","article-title":"Ephrin B2\/EphB4 pathway in hepatic stellate cells stimulates Erk-dependent VEGF production and sinusoidal endothelial cell recruitment","volume":"298","author":"Das","year":"2010","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0015","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nrm856","article-title":"Mechanisms and functions of Eph and ephrin signalling","volume":"3","author":"Kullander","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0020","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/nrm1662","article-title":"Eph receptor signalling casts a wide net on cell behaviour","volume":"6","author":"Pasquale","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0025","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0955-0674(97)80113-5","article-title":"The Eph family of receptors","volume":"9","author":"Pasquale","year":"1997","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0030","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1046\/j.1460-9568.2002.02166.x","article-title":"Ephrin-B3-EphA4 interactions regulate the growth of specific thalamocortical axon populations in vitro","volume":"16","author":"Takemoto","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0035","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nn1237","article-title":"Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling","volume":"7","author":"Himanen","year":"2004","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0040","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nrc2806","article-title":"Eph receptors and ephrins in cancer: bidirectional signalling and beyond","volume":"10","author":"Pasquale","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2018.01.003_bb0045","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1161\/01.ATV.0000055440.89758.C2","article-title":"Distinct roles of ephrin-B2 forward and EphB4 reverse signaling in endothelial cells","volume":"23","author":"Hamada","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0050","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0092-8674(00)80500-0","article-title":"Unified nomenclature for Eph family receptors and their ligands, the ephrins","volume":"90","author":"Eph Nomenclature Committee","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2018.01.003_bb0055","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/414933a","article-title":"Crystal structure of an Eph receptor-ephrin complex","volume":"414","author":"Himanen","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2018.01.003_bb0060","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0092-8674(00)81436-1","article-title":"Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4","volume":"93","author":"Wang","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2018.01.003_bb0065","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S1097-2765(00)80342-1","article-title":"Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development","volume":"4","author":"Gerety","year":"1999","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbcan.2018.01.003_bb0070","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/nrm.2015.16","article-title":"Mechanisms of ephrin-Eph signalling in development, physiology and disease","volume":"17","author":"Kania","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0075","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1146\/annurev-pharmtox-011112-140226","article-title":"Eph receptors and ephrins: therapeutic opportunities","volume":"55","author":"Barquilla","year":"2015","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0080","article-title":"Targeting receptor tyrosine kinase EphB4 in cancer therapy","volume":"S1044\u2013579","author":"Chen","year":"2017","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0085","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1158\/0008-5472.CAN-07-0525","article-title":"Paradoxes of the EphB4 receptor in cancer","volume":"67","author":"Noren","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0090","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/bcr2207","article-title":"Eph receptors in breast cancer: roles in tumor promotion and tumor suppression","volume":"10","author":"Vaught","year":"2008","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0095","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009159","article-title":"Eph receptor signaling and ephrins","volume":"5","author":"Lisabeth","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0100","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/sj.onc.1203304","article-title":"Replacing two conserved tyrosines of the EphB2 receptor with glutamic acid prevents binding of SH2 domains without abrogating kinase activity and biological responses","volume":"19","author":"Zisch","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2018.01.003_bb0105","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.str.2005.11.011","article-title":"Structure and thermodynamic characterization of the EphB4\/ephrin-B2 antagonist peptide complex reveals the determinants for receptor specificity","volume":"14","author":"Chrencik","year":"2006","journal-title":"Structure"},{"key":"10.1016\/j.bbcan.2018.01.003_bb0110","doi-asserted-by":"crossref","first-page":"28185","DOI":"10.1074\/jbc.M605766200","article-title":"Structural and biophysical characterization of the EphB4-ephrinB2 protein-protein interaction and receptor specificity","volume":"281","author":"Chrencik","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0115","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.bbapap.2014.07.002","article-title":"Promiscuous and specific recognition among ephrins and Eph receptors","volume":"1844","author":"Dai","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbcan.2018.01.003_bb0120","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1083\/jcb.200801192","article-title":"Induction of cell retraction by the combined actions of Abl-CrkII and Rho-ROCK1 signaling","volume":"183","author":"Huang","year":"2008","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0125","doi-asserted-by":"crossref","first-page":"630","DOI":"10.4161\/cbt.20080","article-title":"EphB4 promotes or suppresses Ras\/MEK\/ERK pathway in a context-dependent manner implications for EphB4 as a cancer target","volume":"13","author":"Xiao","year":"2012","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0130","doi-asserted-by":"crossref","first-page":"E614","DOI":"10.1002\/ijc.27392","article-title":"Evidence for a dual function of EphB4 as tumour promoter and suppressor regulated by the absence or presence of the ephrin-B2 ligand","volume":"131","author":"Rutkowski","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2018.01.003_bb0135","doi-asserted-by":"crossref","first-page":"7225","DOI":"10.1007\/s13277-014-1955-4","article-title":"Down-regulation of EphB4 phosphorylation is necessary for esophageal squamous cell carcinoma tumourigenecity","volume":"35","author":"Hu","year":"2014","journal-title":"Tumour Biol."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0140","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/B978-0-12-386503-8.00002-8","article-title":"Essential roles of EphB receptors and EphrinB ligands in endothelial cell function and angiogenesis","volume":"114","author":"Salvucci","year":"2012","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0145","first-page":"1197","article-title":"Ephrin-B2 overexpression enhances integrin-mediated ECM-attachment and migration of B16 melanoma cells","volume":"27","author":"Meyer","year":"2005","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0150","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/ijc.24849","article-title":"The phosphorylation of ephrin-B2 ligand promotes glioma cell migration and invasion","volume":"126","author":"Nakada","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2018.01.003_bb0155","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ceb.2008.01.011","article-title":"Eph-ephrin signalling in adult tissues and cancer","volume":"20","author":"Merlos-Su\u00e1rez","year":"2008","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0160","doi-asserted-by":"crossref","first-page":"18575","DOI":"10.1074\/jbc.M109.075085","article-title":"EphA2 mutation in lung squamous cell carcinoma promotes increased cell survival, cell invasion, focal adhesions, and mammalian target of rapamycin activation","volume":"285","author":"Faoro","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044591","article-title":"Mutations of the EPHB6 receptor tyrosine kinase induce a pro-metastatic phenotype in non-small cell lung cancer","volume":"7","author":"Bulk","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbcan.2018.01.003_bb0170","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/jnci\/djs297","article-title":"Effects of cancer-associated EPHA3 mutations on lung cancer","volume":"104","author":"Zhuang","year":"2012","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0175","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1158\/1535-7163.MCT-12-0030","article-title":"Global evaluation of Eph receptors and ephrins in lung adenocarcinomas identifies EphA4 as an inhibitor of cell migration and invasion","volume":"11","author":"Saintigny","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0067668","article-title":"The EphB4 receptor tyrosine kinase promotes lung cancer growth: a potential novel therapeutic target","volume":"8","author":"Ferguson","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbcan.2018.01.003_bb0185","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/sj.leu.2404612","article-title":"Expression and mutation status of candidate kinases in multiple myeloma","volume":"21","author":"Claudio","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.bbcan.2018.01.003_bb0190","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nature05610","article-title":"Patterns of somatic mutation in human cancer genomes","volume":"446","author":"Greenman","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2018.01.003_bb0195","doi-asserted-by":"crossref","DOI":"10.1038\/srep10641","article-title":"Novel EPHB4 receptor tyrosine kinase mutations and kinomic pathway analysis in lung cancer","volume":"5","author":"Ferguson","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0200","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature07423","article-title":"Somatic mutations affect key pathways in lung adenocarcinoma","volume":"455","author":"Ding","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2018.01.003_bb0205","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.cell.2012.08.029","article-title":"Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing","volume":"150","author":"Imielinski","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2018.01.003_bb0210","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/gcc.22109","article-title":"Mutated ephrin receptor genes in non-small cell lung carcinoma and their occurrence with driver mutations targeted resequencing study on formalin-fixed, paraffin-embedded tumour material of 81 patients","volume":"52","author":"M\u00e4ki-Nevala","year":"2013","journal-title":"Genes Chromosom. Cancer"},{"key":"10.1016\/j.bbcan.2018.01.003_bb0215","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3892\/mmr.2012.936","article-title":"EphB4 gene polymorphism and protein expression in non-small-cell lung cancer","volume":"6","author":"Zheng","year":"2012","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0220","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/ijc.21926","article-title":"EphB4 provides survival advantage to squamous cell carcinoma of the head and neck","volume":"119","author":"Masood","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2018.01.003_bb0225","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1177\/014556130308201113","article-title":"Expression of EphB4 in head and neck squamous cell carcinoma","volume":"82","author":"Sinha","year":"2003","journal-title":"Ear Nose Throat J."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0230","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/archotol.132.10.1053","article-title":"The association between elevated EphB4 expression, smoking status, and advanced-stage disease in patients with head and neck squamous cell carcinoma","volume":"132","author":"Sinha","year":"2006","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0235","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1001\/archotol.134.9.985","article-title":"The significance of EphB4 and EphrinB2 expression and survival in head and neck squamous cell carcinoma","volume":"134","author":"Yavrouian","year":"2008","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0240","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3109\/08977194.2014.980904","article-title":"Expression of the EPHB4 receptor tyrosine kinase in head and neck and renal malignancies\u2014implications for solid tumours and potential for therapeutic inhibition","volume":"32","author":"Ferguson","year":"2014","journal-title":"Growth Factors"},{"key":"10.1016\/j.bbcan.2018.01.003_bb0245","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1158\/1078-0432.CCR-04-2109","article-title":"Up-regulation of EphB4 in mesothelioma and its biological significance","volume":"11","author":"Xia","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0250","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1158\/0008-5472.CAN-04-2667","article-title":"EphB4 expression and biological significance in prostate cancer","volume":"65","author":"Xia","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0255","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/1471-2407-13-269","article-title":"EphB4 as a therapeutic target in mesothelioma","volume":"13","author":"Liu","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbcan.2018.01.003_bb0260","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nrd4175","article-title":"Therapeutic targeting of EPH receptors and their ligands","volume":"13","author":"Boyd","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0265","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ejmech.2016.01.057","article-title":"Three stories on Eph kinase inhibitors: from in silico discovery to in vivo validation","volume":"112","author":"Unzue","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0270","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1097\/JTO.0b013e31824c943f","article-title":"Phase II study of the multitargeted tyrosine kinase inhibitor XL647 in patients with non-small-cell lung cancer","volume":"7","author":"Pietanza","year":"2012","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0275","doi-asserted-by":"crossref","first-page":"17301","DOI":"10.1074\/jbc.M500363200","article-title":"EphB receptor-binding peptides identified by phage display enable design of an antagonist with ephrin-like affinity","volume":"280","author":"Koolpe","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0280","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2014.76","article-title":"EphrinA4 mimetic peptide targeted to EphA binding site impairs the formation of long-term fear memory in lateral amygdala","volume":"4","author":"Dines","year":"2014","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bbcan.2018.01.003_bb0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080183","article-title":"Discovery and characterization of a novel cyclic peptide that effectively inhibits ephrin binding to the EphA4 receptor and displays anti-angiogenesis activity","volume":"8","author":"Han","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2018.01.003_bb0290","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1021\/cb500677x","article-title":"Development and structural analysis of a nanomolar cyclic peptide antagonist for the EphA4 receptor","volume":"9","author":"Lamberto","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0295","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.2174\/1389450116666150727115934","article-title":"Targeting the Eph system with peptides and peptide conjugates","volume":"16","author":"Riedl","year":"2015","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.bbcan.2018.01.003_bb0300","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1021\/acsmedchemlett.6b00132","article-title":"Modifications of a nanomolar cyclic peptide antagonist for the EphA4 receptor to achieve high plasma stability","volume":"7","author":"Olson","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0305","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.bcp.2012.12.005","article-title":"Design, synthesis and characterization of novel small molecular inhibitors of ephrin-B2 binding to EphB4","volume":"85","author":"Duggineni","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0310","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.2353\/ajpath.2010.090755","article-title":"Novel EphB4 monoclonal antibodies modulate angiogenesis and inhibit tumour growth","volume":"176","author":"Krasnoperov","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0315","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1182\/blood-2005-04-1655","article-title":"The soluble extracellular domain of EphB4 (sEphB4) antagonizes EphB4 EphrinB2 interaction, modulates angiogenesis, and inhibits tumour growth","volume":"107","author":"Kertesz","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbcan.2018.01.003_bb0320","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1002\/jps.23096","article-title":"Biophysical characterization and stabilization of the recombinant albumin fusion protein sEphB4-HAS","volume":"101","author":"Shi","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0325","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1182\/blood-2008-02-140020","article-title":"The role of Ephs, Ephrins, and growth factors in Kaposi sarcoma and implications of EphrinB2 blockade","volume":"113","author":"Scehnet","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbcan.2018.01.003_bb0330","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-10-641","article-title":"Combination of Dll4\/Notch and Ephrin-B2\/EphB4 targeted therapy is highly effective in disrupting tumour angiogenesis","volume":"10","author":"Djokovic","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbcan.2018.01.003_bb0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081445","article-title":"Attenuation of Eph receptor kinase activation in cancer cells by coexpressed ephrin ligands","volume":"8","author":"Falivelli","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2018.01.003_bb0340","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.neuron.2011.05.031","article-title":"Ephrin-mediated cis-attenuation of Eph receptor signaling is essential for spinal motor axon guidance","volume":"71","author":"Kao","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.bbcan.2018.01.003_bb0345","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nn1655","article-title":"Silencing of EphA3 through a cis interaction with ephrinA5","volume":"9","author":"Carvalho","year":"2006","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0350","first-page":"455","article-title":"Coexpression of transcripts encoding EPHB receptor protein tyrosine kinases and their ephrin-Bligands in human small cell lung carcinoma","volume":"5","author":"Tang","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0355","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/icb.2016.128","article-title":"CAR T-cell therapy of solid tumours","volume":"95","author":"Yong","year":"2017","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2017.04.004","article-title":"CAR T-cell therapy for lung cancer and malignant pleural mesothelioma","volume":"187","author":"Zeltsman","year":"2017","journal-title":"Transl. Res."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0365","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.18632\/oncotarget.6595","article-title":"Adoptive immunotherapy using T lymphocytes redirected to glypican-3 for the treatment of lung squamous cell carcinoma","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2018.01.003_bb0370","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1158\/2159-8290.CD-15-0583","article-title":"Mesothelin-targeted CARs: driving T cells to solid tumours","volume":"6","author":"Morello","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0375","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17111845","article-title":"Cell-free RNA content in peripheral blood as potential biomarkers for detecting circulating tumor cells in non-small cell lung carcinoma","volume":"17","author":"Yu","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0380","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1016\/j.bmcl.2008.04.015","article-title":"Inhibitors of the tyrosine kinase EphB4. Part 1:S-based design and optimization of a series of 2,4-bis-anilinopyrimidines","volume":"18","author":"Bardelle","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0385","doi-asserted-by":"crossref","first-page":"5717","DOI":"10.1016\/j.bmcl.2008.09.087","article-title":"Inhibitors of the tyrosine kinase EphB4. Part 2: structure-based discovery and optimisation of 3, 5-bis substituted anilinopyrimidines","volume":"18","author":"Bardelle","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0390","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.bmcl.2006.09.050","article-title":"Design and effective synthesis of novel templates, 3, 7-diphenyl-4-amino-thieno and furo-[3,2-c]pyridines as protein kinase inhibitors and in vitro evaluation targeting angiogenetic kinases","volume":"17","author":"Miyazaki","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0395","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1158\/1078-0432.CCR-06-2590","article-title":"Inhibition of the T790M gatekeeper mutant of the epidermal growth factor receptor by EXEL-7647","volume":"13","author":"Gendreau","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0400","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1016\/j.bmcl.2011.03.009","article-title":"Inhibitors of the tyrosine kinase EphB4. Part 4: discovery and optimization of a benzylic alcoholseries","volume":"21","author":"Barlaam","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0405","doi-asserted-by":"crossref","first-page":"6433","DOI":"10.1021\/jm9009444","article-title":"Structure-based optimization of potent and selective inhibitors of the tyrosine kinaseerythropoietin producing human hepatocellular carcinoma receptor B4 (EphB4)","volume":"52","author":"Lafleur","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0410","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1021\/jm301187e","article-title":"Optimization of inhibitors of the tyrosine kinase EphB4. 2. Cellular potency improvement and binding mode validation by X-ray crystallography","volume":"56","author":"Lafleur","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbcan.2018.01.003_bb0415","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/prot.22028","article-title":"Structure based tailoring of compound libraries for high-throughput screening: discovery of novel EphB4 kinase inhibitors","volume":"73","author":"Kolb","year":"2008","journal-title":"Proteins"},{"key":"10.1016\/j.bbcan.2018.01.003_bb0420","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/sj.onc.1209108","article-title":"PS, EphB4 receptor tyrosine kinase is expressed in bladder cancer and provides signals for cell survival","volume":"25","author":"Xia","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2018.01.003_bb0425","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2353\/ajpath.2006.050889","article-title":"Receptor tyrosine kinase EphB4 is a survival factor in breast cancer","volume":"169","author":"Kumar","year":"2006","journal-title":"Am. J. Pathol."},{"issue":"10","key":"10.1016\/j.bbcan.2018.01.003_bb5000","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/ng.2405","article-title":"Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer","volume":"44","author":"Rudin","year":"2012","journal-title":"Nat. Genet."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X17302111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X17302111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T04:31:18Z","timestamp":1759638678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X17302111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":86,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0304419X17302111"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2018.01.003","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EphB4: A promising target for upper aerodigestive malignancies","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2018.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}